Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v2.4.0.8
Consolidated Statements of Operations (USD $)
 3 Months Ended 9 Months Ended 100 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Other Revenues $ 0 $ 0 $ 0 $ 0 $ 431,461
Operating expenses:          
General and administrative expenses 825,951 451,046 2,271,443 721,565 5,819,918
Research and development expenses 320,345 43,750 951,101 62,356 1,931,341
Total operating expenses 1,146,296 494,796 3,222,544 783,921 7,751,259
Operating loss (1,146,296) (494,796) (3,222,544) (783,921) (7,319,798)
Other (expense) income:          
Interest expense (27,763) (19,596) (83,293) (108,384) (671,887)
Loss on issuance of warrants 0 0 (7,541,693) 0 (7,541,693)
Adjustment to fair value of derivative 1,584,818 0 2,069,693 0 2,069,693
Other income 0 32 0 51 53,977
Total other expense 1,557,055 (19,564) (5,555,293) (108,333) (6,089,910)
Net Income (Loss) $ 410,759 $ (514,360) $ (8,777,837) $ (892,254) $ (13,409,708)
Basic earnings per share          
Net Income (loss) $ 0.01 $ (0.06) $ (0.13) $ (0.13)  
Weighted Common Shares - Basic 71,949,564 8,549,322 65,933,378 6,613,249  
Diluted Eanings per share          
Net Income (loss) $ 0.01 $ (0.06) $ (0.13) $ (0.13)  
Weighted Common Shares - Diluted 72,084,748 8,549,322 65,933,378 6,613,249